
PCMA Urges HHS, DOL, and Treasury to Support Patient Access and Preserve Flexibility in New Fertility Benefits Rule
By Dalita Collins, Director, Policy On July 13, 2026, PCMA submitted comments to the Departments of Health and Human Services (HHS), Labor (DOL), and Treasury in response
With Landmark PBM Reform Enacted, Getting Implementation Right Matters
By Alison LaPidus, Director, Policy & Regulatory Affairs Congress enacted the most comprehensive federal PBM transparency and accountability reforms in history in the Consolidated Appropriations Act (CAA). Now comes the equally important
PCMA Supports CMS Efforts to Create a More Efficient & Interoperable Health Care Ecosystem
On June 15, PCMA submitted comments to CMS on its proposed rule to advance interoperability and electronic prior authorization (ePA) for prescription drugs. The proposal
When Done Right, Prior Authorization Protects Patients and Lowers Costs
Did you know? Every time a doctor prescribes medication, your pharmacy benefit manager (PBM) is working behind the scenes to protect your health and lower your costs. PBMs deploy advanced tools
Why The DOL Proposed Rule Offers No Additional Meaningful Transparency
PBM Reform is Law – DOL Should Withdraw Its Duplicative Proposal The Department of Labor’s proposed rule on “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure”
How PBMs Provide Unique Capabilities to Fight Fraud, Waste, and Abuse
PCMA Urges CMS to Partner with PBMs to Strengthen Real-Time Fraud Detection Fraud, waste, and abuse in the health care system drive up costs for patients, employers, and
